Paediatricians require more information before they routinely co-administer the meningococcal B vaccine with routine infant vaccines.

about

Paediatricians require more information before they routinely co-administer the meningococcal B vaccine with routine infant vaccines.

Item

http://www.wikidata.org/entity/Q39567592

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Paediatricians require more in ...... with routine infant vaccines.

@en

Paediatricians require more in ...... with routine infant vaccines.

@nl

type

Item

label

Paediatricians require more in ...... with routine infant vaccines.

@en

Paediatricians require more in ...... with routine infant vaccines.

@nl

prefLabel

Paediatricians require more in ...... with routine infant vaccines.

@en

Paediatricians require more in ...... with routine infant vaccines.

@nl

P1476

Paediatricians require more in ...... with routine infant vaccines.

@en

P2093

Angelika Wagner

http://www.w3.org/2001/XMLSchema#string

Karl Zwiauer

http://www.w3.org/2001/XMLSchema#string

Ursula Wiedermann

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, controlled trial to assess the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, hib and meningococcal serogroup C combination vaccine administered at 2, 3, 4 and 12-18 months of age

Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system?

Health care providers' and parents' attitudes toward administration of new infant vaccines--a multinational survey.

Lessons from meningococcal carriage studies.

Can hexavalent vaccines be simultaneously administered with pneumococcal or meningococcal conjugate vaccines?

Paediatric homoeopathy in Germany: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS).

A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program.

Advances in the development of vaccines against Neisseria meningitidis.

Use of a multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) for bacterial meningitis prevention.

Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.

P304

e439-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/APA.13100

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

Michael Kundi

P577

2015-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26119881

http://www.w3.org/2001/XMLSchema#string